Stay updated with breaking news from 91307c10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
United Therapeutics (NASDAQ:UTHR – Get Rating) had its price objective decreased by UBS Group from $330.00 to $310.00 in a research note released on Monday morning, The Fly reports. UBS Group currently has a buy rating on the biotechnology company’s stock. Several other analysts have also issued reports on UTHR. JPMorgan Chase & Co. boosted […]
United Therapeutics (NASDAQ:UTHR – Get Rating) had its price objective cut by UBS Group from $330.00 to $310.00 in a report issued on Monday morning, The Fly reports. They currently have a buy rating on the biotechnology company’s stock. UTHR has been the subject of a number of other research reports. LADENBURG THALM/SH SH decreased […]
State of Michigan Retirement System grew its stake in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 1.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 11,632 shares of the biotechnology company’s stock after acquiring an additional 200 […]
Bank of Montreal Can grew its holdings in shares of United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 49.1% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 49,300 shares of the biotechnology company’s stock after purchasing an additional 16,242 shares during the quarter. Bank of Montreal Can’s holdings in United Therapeutics were […]
Nkcfo LLC grew its holdings in United Therapeutics Co. (NASDAQ:UTHR – Get Rating) by 18.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 645 shares of the biotechnology company’s stock after purchasing an additional 100 shares during the period. Nkcfo LLC’s holdings in […]